BR112013000759A2 - composição de gel médico antimicrobiano compreendendo hidroxietilcelulose esterificada - Google Patents

composição de gel médico antimicrobiano compreendendo hidroxietilcelulose esterificada Download PDF

Info

Publication number
BR112013000759A2
BR112013000759A2 BR112013000759A BR112013000759A BR112013000759A2 BR 112013000759 A2 BR112013000759 A2 BR 112013000759A2 BR 112013000759 A BR112013000759 A BR 112013000759A BR 112013000759 A BR112013000759 A BR 112013000759A BR 112013000759 A2 BR112013000759 A2 BR 112013000759A2
Authority
BR
Brazil
Prior art keywords
medical gel
weight
medical
gel
present
Prior art date
Application number
BR112013000759A
Other languages
English (en)
Portuguese (pt)
Inventor
Heinar Thomas
Original Assignee
Brusells Ventures Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brusells Ventures Corp filed Critical Brusells Ventures Corp
Publication of BR112013000759A2 publication Critical patent/BR112013000759A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0058—Biocides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/08—Cellulose derivatives
    • C08J2301/26—Cellulose ethers
    • C08J2301/28—Alkyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
BR112013000759A 2010-07-19 2011-07-18 composição de gel médico antimicrobiano compreendendo hidroxietilcelulose esterificada BR112013000759A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36544410P 2010-07-19 2010-07-19
PCT/CA2011/000829 WO2012009794A1 (en) 2010-07-19 2011-07-18 Antimicrobial medical gel composition comprising etherified hydroxyethylcellulose

Publications (1)

Publication Number Publication Date
BR112013000759A2 true BR112013000759A2 (pt) 2019-10-01

Family

ID=45496403

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013000759A BR112013000759A2 (pt) 2010-07-19 2011-07-18 composição de gel médico antimicrobiano compreendendo hidroxietilcelulose esterificada

Country Status (8)

Country Link
US (1) US8618175B2 (cg-RX-API-DMAC7.html)
EP (1) EP2595480B1 (cg-RX-API-DMAC7.html)
JP (1) JP5881698B2 (cg-RX-API-DMAC7.html)
AU (1) AU2011282427B8 (cg-RX-API-DMAC7.html)
BR (1) BR112013000759A2 (cg-RX-API-DMAC7.html)
CA (1) CA2802356C (cg-RX-API-DMAC7.html)
WO (1) WO2012009794A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201209317B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120150033A1 (en) * 2010-12-13 2012-06-14 Loren Curtis Rauch Antimicrobial ultrasound transmission gel
CN103432600B (zh) * 2013-08-26 2015-01-28 王春红 一种抗菌型医用超声耦合剂及其制备方法
JPWO2016185811A1 (ja) * 2015-05-20 2018-02-22 富士フイルム株式会社 超音波診断用の塗布型接触媒体
US20190015529A1 (en) * 2016-01-10 2019-01-17 Smilesonica Inc. Viscosity and stability modified ultrasound gel
US20190262279A1 (en) * 2016-07-01 2019-08-29 Tissue Tools Llc Water-based emollient compositions and methods of use therefor
US9895453B1 (en) 2016-08-04 2018-02-20 Mark Edward Fenzl Shiny ultrasound gel
US10646597B2 (en) 2016-10-19 2020-05-12 Wiesman Holdings, LLC Coupling agent produced from naturally fermented and sustainable additives
JP7695353B2 (ja) * 2020-11-04 2025-06-18 エコ スプレイ リミティド 接触媒体
WO2024215540A1 (en) * 2023-04-11 2024-10-17 Avava, Inc. Interface medium for dermatological laser treatments

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020061864A1 (en) 1994-09-22 2002-05-23 Geda International Marketing Company Ltd. Antiseptic spermicidal composition and means for its application
DE19639816A1 (de) * 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
GB9626513D0 (en) * 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
FR2770402A1 (fr) 1997-11-05 1999-05-07 Pierre Cohen Gel de conduction ultrasonore pour echographie, doppler et examens electrocardiographiques presentant des proprietes antiseptiques
JP2002087935A (ja) * 2000-09-07 2002-03-27 Kao Corp 皮膚外用剤
DE10348680A1 (de) * 2003-10-15 2005-05-12 Hans Schwarzkopf & Henkel Gmbh Mittel enthaltend Baldrian
ES2331195T3 (es) * 2004-07-15 2009-12-23 Gynaecologiq B.V. Composicion y metodo para imagineria medica de cavidades corporales.
WO2007038855A1 (en) * 2005-10-04 2007-04-12 Sigmacon Medical Products Corporation Medical gel
WO2007046097A2 (en) * 2005-10-21 2007-04-26 Medidermis Ltd. Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof
JP2009525760A (ja) * 2006-02-10 2009-07-16 デユポン・テイト・アンド・ライル・バイオ・プロダクツ・カンパニー・エルエルシー 再生ベースの生分解性1,3−プロパンジオールを含む生分解性組成物
EP2032115B1 (en) * 2006-06-16 2021-07-21 DSM IP Assets B.V. Compositions based on hyperbranched condensation polymers and novel hyperbranched condensation polymers
EP2237795A2 (en) * 2007-12-21 2010-10-13 Coda Therapeutics, Inc. Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions

Also Published As

Publication number Publication date
US8618175B2 (en) 2013-12-31
JP2013535251A (ja) 2013-09-12
EP2595480A4 (en) 2014-06-18
CA2802356A1 (en) 2012-01-26
EP2595480B1 (en) 2016-09-07
ZA201209317B (en) 2013-08-28
EP2595480A1 (en) 2013-05-29
AU2011282427B8 (en) 2014-10-09
WO2012009794A1 (en) 2012-01-26
AU2011282427A8 (en) 2014-10-09
US20130116331A1 (en) 2013-05-09
CA2802356C (en) 2019-05-28
AU2011282427A1 (en) 2013-01-10
AU2011282427B2 (en) 2014-09-18
JP5881698B2 (ja) 2016-03-09

Similar Documents

Publication Publication Date Title
JP5881698B2 (ja) エーテルヒドロキシエチルセルロースを含む抗微生物医療用ジェル
Privitera et al. Skin antisepsis with chlorhexidine versus iodine for the prevention of surgical site infection: a systematic review and meta-analysis
Li et al. Laparoscopic versus conventional appendectomy-a meta-analysis of randomized controlled trials
CN102580121B (zh) 一种医用消毒耦合剂
Anya et al. Comparison of visual estimation of intra-operative blood loss with haemoglobin estimation in patients undergoing caesarean section
Praneeth et al. Chitosan in wound healing: a mini review on ethical perspective on sustainable and biomedical biomaterials
WO2015027752A1 (zh) 一种抗菌型医用超声耦合剂及其制备方法
Ali et al. Clinical and microbiological effects of ultrasonically activated irrigation versus syringe irrigation during endodontic treatment: a systematic review and meta-analysis of randomized clinical trials
Dahake et al. Cytotoxicity of novel polymeric gel matrix triple antibiotic paste—an in vitro study
Kotsiou et al. The role of ATP bioluminescence in monitoring surface hygiene in hospital settings: a comprehensive review
Yilmaz et al. Calcium hypochlorite on mouse embryonic fibroblast cells (NIH3T3) in vitro cytotoxicity and genotoxicity: MTT and comet assay
Schlüter et al. Evaluation of the application of rhino-septal splints in endoscopic transsphenoidal skull base surgery
Farah et al. Reduction of aerosols and splatter generated during ultrasonic scaling by adding food-grade thickeners to coolants: an in-vitro study
CN104721845B (zh) 一种兼有保湿和润肤作用的消毒杀菌型医用超声耦合剂及其制备方法
Hottmann et al. In vitro elution of amikacin from four hydrogel preparations: a pilot study
Baumeister et al. Corneal re-epithelialization following phototherapeutic keratectomy for recurrent corneal erosion as in vivo model of epithelial wound healing
Rayan et al. A case of relapsing Salmonella osteomyelitis in a thalassaemia trait patient
CN110585450A (zh) 医用消毒杀菌型超声耦合剂
AlKhamis et al. Surgical site infections in oral and maxillofacial surgeries: prevalence and associated risk factors
Takeuchi et al. Is the administration of vancomycin to operative field effective? Studying from operative wound drainage tube culture
Kulkarni et al. Meniscal tear as potential steering factor for inflammation may aggravate arthritis: two case reports
HK1184332B (en) Antimicrobial medical gel composition comprising etherified hydroxyethylcellulose
Mueller et al. Repithel®: removing the barriers to wound healing
Gurel et al. Does prebiopsy, nonsterile ultrasonography gel affect biopsy-site asepsis?
Kiernan Reducing the risk of surgical site infection

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B350 Update of information on the portal [chapter 15.35 patent gazette]